CN105381441A - 一种用于防治妊娠水肿的中药胶囊剂及制备方法 - Google Patents
一种用于防治妊娠水肿的中药胶囊剂及制备方法 Download PDFInfo
- Publication number
- CN105381441A CN105381441A CN201510945624.5A CN201510945624A CN105381441A CN 105381441 A CN105381441 A CN 105381441A CN 201510945624 A CN201510945624 A CN 201510945624A CN 105381441 A CN105381441 A CN 105381441A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- chinese medicine
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 58
- 239000002775 capsule Substances 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 14
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 14
- 235000008434 ginseng Nutrition 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 206010030113 Oedema Diseases 0.000 claims description 68
- 230000035935 pregnancy Effects 0.000 claims description 30
- 239000000203 mixture Substances 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 16
- 210000000582 semen Anatomy 0.000 claims description 15
- 241000208340 Araliaceae Species 0.000 claims description 13
- 229940079593 drug Drugs 0.000 claims description 10
- 238000005202 decontamination Methods 0.000 claims description 9
- 230000003588 decontaminative effect Effects 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 7
- 241000207929 Scutellaria Species 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- -1 mixing Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 235000019991 rice wine Nutrition 0.000 claims description 6
- 235000015099 wheat brans Nutrition 0.000 claims description 6
- 238000012545 processing Methods 0.000 claims description 5
- 239000004375 Dextrin Substances 0.000 claims description 3
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 235000019504 cigarettes Nutrition 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 241000545442 Radix Species 0.000 claims 3
- 210000000952 spleen Anatomy 0.000 abstract description 32
- 208000011580 syndromic disease Diseases 0.000 abstract description 29
- 210000004369 blood Anatomy 0.000 abstract description 28
- 239000008280 blood Substances 0.000 abstract description 28
- 230000000694 effects Effects 0.000 abstract description 27
- 210000003734 kidney Anatomy 0.000 abstract description 27
- 208000004880 Polyuria Diseases 0.000 abstract description 16
- 230000035619 diuresis Effects 0.000 abstract description 16
- 210000004072 lung Anatomy 0.000 abstract description 15
- 230000003213 activating effect Effects 0.000 abstract description 14
- 230000007812 deficiency Effects 0.000 abstract description 10
- 230000001105 regulatory effect Effects 0.000 abstract description 10
- 238000010792 warming Methods 0.000 abstract description 9
- 210000003754 fetus Anatomy 0.000 abstract description 8
- 230000008961 swelling Effects 0.000 abstract description 8
- 208000031320 Teratogenesis Diseases 0.000 abstract description 7
- 210000002216 heart Anatomy 0.000 abstract description 6
- 210000001161 mammalian embryo Anatomy 0.000 abstract description 5
- 206010000234 Abortion spontaneous Diseases 0.000 abstract description 2
- 208000015994 miscarriage Diseases 0.000 abstract description 2
- 208000000995 spontaneous abortion Diseases 0.000 abstract description 2
- 240000006995 Abutilon theophrasti Species 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 244000080767 Areca catechu Species 0.000 abstract 1
- 235000006226 Areca catechu Nutrition 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 241001448331 Liriope spicata Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 241001369613 Stephania tetrandra Species 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 16
- 230000001737 promoting effect Effects 0.000 description 16
- 210000004185 liver Anatomy 0.000 description 14
- 230000036407 pain Effects 0.000 description 14
- 206010016807 Fluid retention Diseases 0.000 description 13
- 208000006820 Arthralgia Diseases 0.000 description 12
- 210000002700 urine Anatomy 0.000 description 12
- 230000001717 pathogenic effect Effects 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 210000003414 extremity Anatomy 0.000 description 10
- 230000017531 blood circulation Effects 0.000 description 9
- 210000000038 chest Anatomy 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 210000002683 foot Anatomy 0.000 description 9
- 244000052769 pathogen Species 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 206010007247 Carbuncle Diseases 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 208000031975 Yang Deficiency Diseases 0.000 description 7
- 230000036772 blood pressure Effects 0.000 description 7
- 210000000988 bone and bone Anatomy 0.000 description 7
- 230000002612 cardiopulmonary effect Effects 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 210000003423 ankle Anatomy 0.000 description 6
- 230000036528 appetite Effects 0.000 description 6
- 235000019789 appetite Nutrition 0.000 description 6
- 208000002173 dizziness Diseases 0.000 description 6
- 239000002689 soil Substances 0.000 description 6
- 230000035922 thirst Effects 0.000 description 6
- 238000012790 confirmation Methods 0.000 description 5
- 206010013990 dysuria Diseases 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 210000001624 hip Anatomy 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 210000002414 leg Anatomy 0.000 description 5
- 210000001699 lower leg Anatomy 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 210000000689 upper leg Anatomy 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 4
- 206010067482 No adverse event Diseases 0.000 description 4
- 208000005392 Spasm Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 208000002894 beriberi Diseases 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 210000003141 lower extremity Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 230000035807 sensation Effects 0.000 description 4
- 230000002269 spontaneous effect Effects 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 210000003932 urinary bladder Anatomy 0.000 description 4
- 238000012795 verification Methods 0.000 description 4
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 206010021118 Hypotonia Diseases 0.000 description 3
- 206010040007 Sense of oppression Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 230000003187 abdominal effect Effects 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 230000001605 fetal effect Effects 0.000 description 3
- 208000017561 flaccidity Diseases 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 239000012567 medical material Substances 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 208000013220 shortness of breath Diseases 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 210000004291 uterus Anatomy 0.000 description 3
- MJPMPMZXJIZPRE-UHFFFAOYSA-N 3-butyl-5,6,7,7a-tetrahydro-3h-2-benzofuran-1-one Chemical compound C1CCC=C2C(CCCC)OC(=O)C21 MJPMPMZXJIZPRE-UHFFFAOYSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010001580 Albuminuria Diseases 0.000 description 2
- 241001480043 Arthrodermataceae Species 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- FINHMKGKINIASC-UHFFFAOYSA-N Tetramethylpyrazine Chemical compound CC1=NC(C)=C(C)N=C1C FINHMKGKINIASC-UHFFFAOYSA-N 0.000 description 2
- 241000223238 Trichophyton Species 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000002052 anaphylactic effect Effects 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 230000037304 dermatophytes Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000002497 edematous effect Effects 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 238000007373 indentation Methods 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 208000012113 pregnancy disease Diseases 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 208000011726 slow pulse Diseases 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 208000027219 Deficiency disease Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010070538 Gestational hypertension Diseases 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 201000005624 HELLP Syndrome Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 241000521257 Hydrops Species 0.000 description 1
- 208000029422 Hypernatremia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 208000008763 Mercury poisoning Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010029174 Nerve compression Diseases 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 206010058117 Ocular icterus Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010060932 Postoperative adhesion Diseases 0.000 description 1
- 208000005347 Pregnancy-Induced Hypertension Diseases 0.000 description 1
- 244000018795 Prunus mume Species 0.000 description 1
- 235000011158 Prunus mume Nutrition 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 206010039705 Scleritis Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041277 Sodium retention Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241001312524 Streptococcus viridans Species 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229940118377 Vitamin antagonist Drugs 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000001062 anti-nausea Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000003913 calcium metabolism Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 210000002458 fetal heart Anatomy 0.000 description 1
- 210000003811 finger Anatomy 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 208000027692 gas pain Diseases 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000008991 intestinal motility Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 230000000292 leukogenic effect Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 210000004880 lymph fluid Anatomy 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 208000036335 preeclampsia/eclampsia 1 Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 150000005856 steroid saponins Chemical class 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于防治妊娠水肿的中药胶囊剂及制备方法,属中药领域。本发明中药有效成分的原料组成及重量份数为:山药15~30份、土茯苓15~30份、桑枝15~30份、土麦冬15~30份、干姜5~15份、白术5~15份、泽泻5~15份、续断5~15份、当归5~15份、冬葵子5~15份、人参5~15份、川芎3~10份、五加皮3~10份、赤芍3~10份、防己3~10份、黄芩3~10份、大腹皮3~10份。本发明针对脾虚证型、肾阳虚型、水迫心肺型、气滞水停型、寒湿证型引发的妊娠水肿组方,养血清热、化湿消肿、温肾利水、健脾安胎、理气行滞、散寒去湿,对母体、胚胎、胎儿无不良反应,无致畸现象,吸收效果较好,治愈率高达高,适于临床推广应用。
Description
所属技术领域
本发明涉及中药领域,尤其涉及一种用于防治妊娠水肿的中药胶囊剂及制备方法,选用药材符合君臣左使之理,针对脾虚证型、肾阳虚型、水迫心肺型、气滞水停型、寒湿证型引发的妊娠水肿,具有养血清热、化湿消肿、温肾利水、健脾安胎、理气行滞、散寒去湿、通阳利水之功效。
背景技术
妊娠水肿是指妊娠后,肢体面目等部位发生浮肿,称“妊娠水肿”,亦称“妊娠肿胀”。主要由于孕妇内分泌发生改变,致使体内组织中水分及盐类潴留(钠潴留);另外,妊娠子宫压迫盆腔及下肢的静脉,阻碍血液回流,使静脉压增高,故水肿经常发生在肢远端,以足部及小腿为主。
西医临床诊断为,妊娠水肿主要分为:
(1)生理性水肿,主要是由于子宫压迫造成,增大的子宫会压迫从心脏经骨盆到双腿的血管。血液和淋巴液循环不畅,代谢不良,导致腿部组织体液淤积,一般多发生在脚踝或膝盖以下处,通常孕妇在早晨起床时并不会有明显症状,但在经过白天久站和夜间活动量减少后,大约在晚上睡觉前,水肿症状就会比较明显。并且在一天的不同时间中,水肿的部位不同,如果把脚抬高1小时,腿部和脚踝的水肿会减轻,其血压在正常范围内,产检时尿液检测没有尿蛋白,由于生理性水肿大致不会对胎儿造成不良影响,并且这种水肿产后会自愈,所以准妈妈不用过分担心;
(2)病态性水肿,多由疾病造成,例如妊娠毒血症、肾脏病、心脏病或其他肝脏方面的疾病等,这些疾病不仅会对准妈妈的身体造成不同程度的影响,对胎儿的健康也会有危害。且病态性水肿的症状不仅呈现在下肢部位、双手、脸部、腹部等都有可能发生。如果用手轻按肌肤时,肌肤反应多会呈现下陷、没有弹性、肤色暗蓝等现象。如果准妈妈遭遇的是病理性水肿则需及时就医,寻求医生帮助治疗。因为浮肿可能会导致神经受压,有时则会引起大腿外侧发麻、指尖刺痛,或感觉丧失。
水肿最初可表现为体重的异常增加(即隐性水肿),每周超过0.5kg,或出现凹陷性水肿,即体内积液过多而导致的临床可见水肿,多由踝部开始,渐延到小腿、大腿、外阴部、腹部,按之凹陷。水肿分为四级,用“+”表示。“+”水肿局限于踝部和小腿;“++”水肿延及大腿;“+++”水肿延及外阴和腹部;“++++”全身水肿或伴腹水。
传统中医理论认为:妊娠水肿主要有脾虚证型、肾阳虚型、水迫心肺型、气滞水停型、寒湿证型妊娠水肿等。临床表现为:
(1)妊娠数月,面目四肢浮肿或遍及全身,伴胸闷气短、口淡无味、食欲不振、大便溏薄,舌质胖嫩,苔薄白或腻、边有齿痕,脉缓滑无力;
(2)妊娠数月,面浮肢肿,尤以腰以下为甚,四肢欠温、腰膝无力,舌质淡或边有齿痕,苔白润,脉沉迟;
(3)妊娠数月,肢体肿胀,始肿两足,渐及于腿,皮色不变,压痕不显,头晕胀痛,胸胁胀满,飮食减少,苔薄腻,脉弦滑。
目前,对于各种证型的妊娠水肿病主要采用中药治疗,市面上有一些治疗妊娠水肿的中药,大多都是专属治疗某种证型的妊娠水肿病的中药,不能够综合性的针对多种病因引发的多种证型妊娠水肿的中药治疗手段。
为解决上述缺陷,本发明的中药制剂,针对脾虚证型、肾阳虚型、水迫心肺型、气滞水停型、寒湿证型引发的妊娠水肿,具有养血清热、化湿消肿、温肾利水、健脾安胎、理气行滞、散寒去湿、通阳利水之功效。经临床验证本发明的药物对母体、胚胎、胎儿无不良反应,未出现致畸现象,吸收效果较好,方便携带,治愈率高达90%。
发明内容
本发明提供了一种用于防治妊娠水肿的中药胶囊剂及制备方法,本发明选用药材符合君臣左使之理,针对脾虚证型、肾阳虚型、水迫心肺型、气滞水停型、寒湿证型引发的妊娠水肿,具有养血清热、化湿消肿、温肾利水、健脾安胎、理气行滞、散寒去湿、通阳利水之功效,经临床验证本发明的药物对母体、胚胎、胎儿无不良反应,未出现致畸现象,吸收效果较好,治愈率高达90%.
为实现上述目的,本发明的技术方案实施如下:
一种用于防治妊娠水肿的中药胶囊剂及制备方法,制成所述中药有效成分的原料组成及重量份数为:
山药15g~30g土茯苓15g~30g桑枝15g~30g土麦冬15g~30g
干姜5g~15g白术5g~15g泽泻5g~15g续断5g~15g当归5g~15g
冬葵子5g~15g人参5g~15g川芎3g~10g五加皮3g~10g
赤芍3g~10g防己3g~10g黄芩3g~10g大腹皮3g~10g。
制成所述中药有效成分的原料组成及重量份数为:
山药19g~26g土茯苓19g~26g桑枝19g~26g土麦冬19g~26g
干姜8g~12g白术8g~12g泽泻8g~12g续断8g~12g当归8g~12g
冬葵子8g~12g人参8g~12g川芎4g~7g五加皮4g~7g
赤芍4g~7g防己4g~7g黄芩4g~7g大腹皮4g~7g。
制成所述中药有效成分的原料组成及重量份数为:
山药25g土茯苓25g桑枝25g土麦冬25g
干姜10g白术10g泽泻10g续断10g当归10g
冬葵子10g人参10g川芎5g五加皮5g
赤芍5g防己5g黄芩5g大腹皮5g。
一种用于防治妊娠水肿的中药胶囊剂的制备方法,包括以下工艺步骤:
1)先将麸皮撒入热锅内,候烟冒出时,将山药、白术、泽泻分别倒入微炒至表面呈淡黄色,取出,筛去麸皮后放凉,粉碎成粉末,过80目筛,备用;
(2)将土茯苓、桑枝、土麦冬、干姜、冬葵子、人参、防己、大腹皮分别拣去杂质,粉碎成粉末,过80目筛,备用;
(3)将当归、川芎、五加皮、黄芩分别拣去杂质,洗净,切片晒干,取当归片、川芎片、五加皮、黄芩片分别喷淋绍兴黄酒(与绍兴黄酒分比为10:1),拌匀,用文火微炒至表面呈微黄色,取出,放凉,粉碎成粉末,过80目筛,备用;
(4)将续断、赤芍分别去拣去杂质,洗净后切片,晒干,取续断片、赤芍片分别入锅内以文火炒至表面微焦,取出,放凉,粉碎成粉末,过80目筛,备用;
(5)将步骤1、步骤2、步骤3、步骤4所得的粉末,倒入容器中混合拌匀,加入药量的9倍量的水进行煎煮至沸腾后,继续用文火煎煮40分钟,滤出药液,将滤得的药液浓缩至为75℃环境下相对密度1.20的稠膏,进行低温干燥,粉碎,加入适量糊精,混匀,制粒,低温干燥,整粒,装入胶囊,即得。
本发明所用中药的药性如下:
山药:味甘;性平。入肺;脾;肾经。补脾;养肺;固肾;益精。主治脾虚泄泻;食少浮肿;肺虚咳喘;消渴;遗精;带下;肾虚尿频;外用治痈肿;瘰疬。《本草正》载:“山药,能健脾补虚,滋精固肾,治诸虚百损,疗五劳七伤。”现代医学研究证实,山药能降低血糖,调节机体对非特异刺激反应性,有效对抗环磷酰胺的抑制免疫作用,刺激小肠运动,促进肠道内容物排空,此外还能助消化、止泻、祛痰。
土茯苓:味甘;淡;性平。入肝;胃;脾经。清热除湿;泄浊解毒;通利关节。主治梅毒;淋浊;泄泻;筋骨挛痛;脚气;痈肿;疮癣;瘰疬;瘿瘤及汞中毒。《纲目》载:“健脾胃,强筋骨,去风湿,利关节,止泄泻。治拘挛骨痛,恶疮痈肿,解汞粉、银朱毒。”
桑枝:味苦;性平。入肺;肾二经。祛风湿;利关节;行水气。治风寒湿痹;四肢拘挛;脚气浮肿;中风半身不遂;肌体风痒;用于肩臂、关节酸痛麻木。《本草图经》载:“疗遍体风痒干燥,脚气风气,四肢拘挛。”现代医学研究证实,桑枝对肩周炎有明显疗效,能防治II区屈指肌腱术后黏连。
土麦冬:味甘;微苦;性微寒。归心;肺;胃经。养阴生津;润肺清心。主治肺燥干咳,阴虚痨嗽,喉痹咽痛,津伤口渴,内热消渴,心烦失眠,肠燥便秘。《名医别录》载:“麦冬疗身重目黄,心下支满,虚劳客热,口干烦渴,止呕吐,愈痿蹶,强阴益精,消谷调中,保神,定肺气,安五脏,令人肥健。”现代医学研究证实,麦冬含有多种甾体皂甙、胡萝卜素、粘液质、糖类、豆甾醇等成分,有升高白细胞,延长抗体存在时间的作用,同时提高免疫功能和核酸合成率,促进抗体、补体、干扰素、溶菌酶等免疫物质的产生,有增强正气、加强抗邪作用。
干姜:味辛;性热。归脾;胃;心;肺经。具有温中散寒;回阳通脉;温肺化饮。主治脘腹冷痛;呕吐;泄泻;亡阳厥逆;寒饮喘咳;寒湿痹痛。《药性论》载:治腰肾中疼冷,冷气,破血,去风,通四肢关节,开五脏六腑,去风毒冷痹,夜多小便。治嗽,主温中,霍乱不止,腹痛,消胀满冷痢,治血闭。病人虚而冷,宜加用之。
白术:味苦;甘;性温。归脾;胃经。健脾益气;燥湿利水;止汗;安胎。主治脾气虚弱;神疲乏力;食少腹胀;大便溏薄;水饮内停;小便不利;水肿;痰饮眩晕;湿痹酸痛;气虚自汗;胎动不安。《本经逢原》载:“术,生用有除湿益燥,消痰利水,治风寒湿痹,死肌痉疸,散腰脐间血,及冲脉为病,逆气里急之功;制熟则有和中补气,止渴生津,止汗除热,进饮食,安胎之效。”现代医学研究证实,白术有强壮和提高机体抗病能力的作用,增强网状内皮系统的吞噬功能,增强白细胞吞噬金黄色葡萄球菌的功能,对白细胞减少症有升白作用,提高淋巴细胞转化率,促进细胞免疫功能,对金黄色葡萄球菌、溶血性链球菌、绿色链球菌、肺炎球菌、脑膜炎球菌、白喉杆菌、枯草杆菌有不同程度的抑制作用,对絮状表皮癣菌、星形奴卡菌、堇色毛癣菌、同心性毛癣菌等皮肤真菌有一定的抑制作用。
泽泻:味甘;淡;性寒。归肾;膀胱经。利水渗湿;泄热通淋。主治小便不利;热淋涩痛;水肿胀满;泄泻;痰饮眩晕;遗精。《别录》载:“补虚损五劳,除五脏痞满,起阴气,止泄精、消渴、淋沥,逐膀胱、三焦停水。”现代医学研究证实,泽泻有降低胆固醇及防止动脉粥样硬化作用,改善肝脂肪代谢,降低血糖、血压,影响免疫系统功能,降低血清溶血素。
续断:味苦;辛;性微温。归肝;肾经。补肝肾;强筋骨;调血脉;续折伤;止崩漏。用于腰背酸疼;肢节痿痹;跌扑创伤;损盘折骨;痈疽疮肿。《证治准绳》载:“甘温助阳,辛以散瘀,兼有补益肝肾,强健壮骨,通利血脉之功。”现代医学研究证实,续断含有多种生物碱和微量元素钛,有抗维生素E缺乏症的作用,对痈疡有排脓、止血、镇痛、促进组织再生的作用。
当归:味甘;辛;性温。归肝、心、脾经。补血活血;调经止痛;润肠通便。主治血虚萎黄;眩晕心悸;虚寒腹痛;风湿痹痛;跌扑损伤;痈疽疮疡。《本草正》载:“其味甘而重,故专能补血,其气轻而辛,故又能行血,能养营养血,补气生精,安五脏,强形体,益神志,凡有形虚损之病,无所不宜。”现代医学研究证实,当归具有抗菌、消炎作用,对慢性风湿关节炎急性发作有明显的抑制作用。
冬葵子:味甘;寒。归大肠;小肠;肝;肺;胃;膀胱经。具有利水通淋;滑肠通便;下乳。主治淋病;水肿;大便不通;乳汗不行。现代医学研究证实,冬葵子具有利水;健脾;安神等作用。
人参:味苦;微苦;性微温。归肺;脾心;肾经。具有大补元气;补脾益气;生津止渴;安神益短。主治劳伤虚损;食少;倦怠;反胃吐食;大便滑泄;虚咳喘促;自汗暴脱;惊悸;健忘;眩晕头痛;阳萎;尿频;消渴;妇女崩漏;小儿慢惊;久虚不复;气血津液不足之证。
川芎:味辛;性温。归肝;胆;心包经。活血祛瘀;行气开郁;祛风止痛。主治癓瘕肿块;胸胁疼痛;头痛眩晕;风寒湿痹;跌打损伤;痈疽疮疡。《本草正》载:“散风寒,治痛,破瘀蓄,通血脉,解结气,逐疼痛,排脓消肿,逐血通经。”现代医学科学研究发现,川芎提取液对抑制白血病细胞有一定作用,制剂有一定的抗菌作用,尤其是对伤寒杆菌、副伤寒杆菌、霍乱弧菌、绿脓杆菌及致病性皮肤真菌等均有抑制作用,川芎所含的川芎嗪、阿魏酸纳具有活血化瘀功效,可扩张冠状动脉,增进冠脉流量,缓解心绞痛,并具有抗血栓形成作用,所含的川芎内酯有平滑肌解痉和抑制肠肌、子宫收缩等作用。
五加皮:味辛;苦;微甘;性温。归肝;肾经。具有祛风湿;补肝肾;强筋骨;活血脉。主治风寒湿痹;腰膝疼痛;筋骨痿软;小数点儿行迟;体虚赢弱;跌打损伤;骨折;水肿;脚气;阴下湿痒。《陕西中草药》载:活血消肿,治风湿关节痛,阴囊湿疹,跌打损伤,水肿,小便不利。
赤芍:味苦;微寒。归肝经。清热凉血;散瘀止痛。主治温毒发斑,吐血衄血;目赤肿痛;肝郁胁痛;经闭痛经;症瘕腹痛;跌扑损伤;痈肿疮疡。《神农本草经》载:“味苦平,主邪气腹痛,除血痹、破坚积寒热疝瘕、止痛,生川谷。”现代医学研究证实,赤芍对高黏滞血冠心病患者有改变血液流变性的作用,可使全血黏度比及红细胞电泳时间降低,能通过影响钙代谢拮抗动脉粥样硬化,水醇提取物有显著的镇静作用及止痛效果,能轻度提高胃液的酸度,可用于改进食欲、消化机能及某些神经疾患。
防己:味苦;辛;性寒,平。归肝;脾;肾;太阳经。祛风止痛;清热利水。主治湿热身痛;风湿痹痛;下肢水肿;小便不利;脚气肿痛。《别录》载:“疗水肿、风肿,去膀胱热,伤寒寒热邪气,中风手脚挛急,止泄,散痈肿恶结,治诸瘑疥癣虫疮,通腠理,利九窍。”现代医学研究发现,防己所含的木防己碱有镇静、消炎、镇痛和降温等中枢抑制作用,有广泛的抗过敏作用,既是过敏介质的拮抗剂,也是过敏介质的阻滞剂,能加强心脏的收缩力,对心肌梗死有保护作用,能扩张冠状血管,降低血压,松驰横纹肌,抗病原微生物,以及显著的抗癌作用。
黄芩:味苦;性寒。归肺;胆;脾;胃;大肠;小肠经。清热燥湿;泻火解毒;止血安胎;降血压。主治湿温、暑湿胸闷呕恶;湿热痞满;泻痢;黄疸;肺热咳嗽;血热吐衄;痈肿疮毒;胎动不安。《本经》载:“主诸热黄疸,肠僻,泄利,逐水,下血闭,恶疮,疽蚀,火疡。”现代医学研究证实,黄芩有显著的抑菌、抗真菌、抗病毒、抗炎、抗变态反应等作用,能降低血压、抑制血小板聚集、抗凝、降血脂,此外还有保肝、利胆、抗氧化、抗癌功效。
大腹皮:味辛;性微温。入脾;胃;大肠;小肠经。下气宽中;行水消肿。主治胸腹胀闷;水肿;脚气;小便不利。《本草再新》载:“泻肺,和胃气,利湿追风,宽肠消肿,理腰脚气,治疟疾泻痢。“现代医学研究证实,大腹皮能提高肠管紧张性,减少收缩幅度,具有调节肠平滑肌的功能。
本发明与现有技术相比,具有以下有益效果:
本发明选用药材符合君臣左使之理,针对脾虚证型、肾阳虚型、水迫心肺型、气滞水停型、寒湿证型引发的妊娠水肿,具有养血清热、化湿消肿、温肾利水、健脾安胎、理气行滞、散寒去湿、通阳利水之功效。经临床验证本发明的药物对母体、胚胎、胎儿无不良反应,未出现致畸现象,吸收效果较好,方便携带,治愈率高达90%。
具体实施方式
下面结合具体实施例对本发明做进一步阐述。
实施例1
本发明中药有效成分的原料组成及重量为:
山药25g土茯苓25g桑枝25g土麦冬25g
干姜10g白术10g泽泻10g续断10g当归10g
冬葵子10g人参10g川芎5g五加皮5g
赤芍5g防己5g黄芩5g大腹皮5g。
本发明中药制备方法的工艺步骤为:
(1)先将麸皮撒入热锅内,候烟冒出时,将山药、白术、泽泻分别倒入微炒至表面呈淡黄色,取出,筛去麸皮后放凉,粉碎成粉末,过80目筛,备用;
(2)将土茯苓、桑枝、土麦冬、干姜、冬葵子、人参、防己、大腹皮分别拣去杂质,粉碎成粉末,过80目筛,备用;
(3)将当归、川芎、五加皮、黄芩分别拣去杂质,洗净,切片晒干,取当归片、川芎片、五加皮、黄芩片分别喷淋绍兴黄酒(与绍兴黄酒分比为10:1),拌匀,用文火微炒至表面呈微黄色,取出,放凉,粉碎成粉末,过80目筛,备用;
(4)将续断、赤芍分别去拣去杂质,洗净后切片,晒干,取续断片、赤芍片分别入锅内以文火炒至表面微焦,取出,放凉,粉碎成粉末,过80目筛,备用;
(5)将步骤1、步骤2、步骤3、步骤4所得的粉末,倒入容器中混合拌匀,加入药量的9倍量的水进行煎煮至沸腾后,继续用文火煎煮40分钟,滤出药液,将滤得的药液浓缩至为75℃环境下相对密度1.20的稠膏,进行低温干燥,粉碎,加入适量糊精,混匀,制粒,低温干燥,整粒,装入胶囊,即得。
用法与用量:每次3g~5粒,每日2次,与饭前、饭后2小时服用,5天为1个疗程。
实施例2
本发明中药有效成分的原料组成及重量为:
山药17g土茯苓17g桑枝17g土麦冬17g
干姜6g白术6g泽泻6g续断6g当归6g
冬葵子6g人参6g川芎3.5g五加皮3.5g
赤芍3.5g防己3.5g黄芩3.5g大腹皮3.5g。
本实施例的药物制备方法工艺步骤及用法用量与实施例1相同。
实施例3
本发明中药有效成分的原料组成及重量为:
山药28g土茯苓28g桑枝28g土麦冬28g
干姜13g白术13g泽泻13g续断13g当归13g
冬葵子13g人参13g川芎8g五加皮8g
赤芍8g防己8g黄芩8g大腹皮8g。
本实施例的药物制备方法工艺步骤及用法用量与实施例1相同。
临床资料:
1、病例选择
发明人于2005年10月g~2014年3月统计有240例脾虚证型、肾阳虚型、水迫心肺型、气滞水停型、寒湿证型妊娠水肿的临床观察,病人随机分成两组。治疗组120例,对照组120例,平均年龄在24g~38岁,病程为15g~28天,两组资历基本一致,无显著差异,具有可比性。
2、治疗组患者服用本发明药物,按照具体实施例1制得的胶囊剂,早、晚各服一次,每次服3粒,服用2个疗程,重症者为每次服5粒服用2个疗程。对照组根据诊断出的妊娠水肿的类别,分别予以茯苓汤、五皮饮,按照说明书服用。疗程10天。
3、疗效判定:
(1)痊愈:脚盘、脚踝、手指、手背、小腿、大腿无肿胀现象,无高血压症状,尿液检测无尿蛋白,无胸闷气短,大、小便正常。
(2)好转:无高血压症状,尿液检测无尿蛋白,脚盘、脚踝、手指、小腿、大腿肿胀已减轻,无胸闷,大、小便正常。
(3)无效:症状同施治前无明显差异。
4、结果
组别 | n | 痊愈 | 好转 | 无效 | 治愈率% | 总有效率(%) |
治疗组 | 120 | 86 | 22 | 12 | 71% | 90% |
对照组 | 120 | 56 | 19 | 45 | 46% | 62.5% |
以上结果显示,治疗组的治愈率和总有效率明显高于对照组。
典型病例举例:
病例1
秦女士,28岁,患者自述,怀孕7个半月,前一段时间有轻微水肿,最近水肿的厉害,手部、大腿、小腿部水肿,体重也增加了很多,在医院化验尿蛋白2+,并且血压升高,舌质淡,苔白润,脉沉迟,气滞水停型妊娠水肿应以理气行滞、通阳利水的治疗原则。患者服用本发明中药3日,水肿部位逐渐消肿,连续服用5日,症状基本消失,血压测量恢复正常值,做尿检无蛋白尿,胎心监护正常,回家休息直至产期来到我院自然分娩一名男婴,对婴儿的各项指标显示,未发现致畸现象,母子平安健康。
病例2
张女士,32岁,患者自述,怀孕4个月,出现轻微水肿,休息一晚上,早上就恢复了,一个星期后,水肿的越厉害了,早上也是肿的,食欲下降,还经常伴有胸闷,来医院测量血压低压100、高压150,做尿检未发现蛋白尿,诊断为面目四肢浮肿,伴胸闷气短,食欲不振,大便溏薄,舌质胖嫩,苔薄白,脉缓滑无力,脾虚型水肿应以健脾安胎、化湿消肿的治疗原则。患者服用本发明中药1疗程,胃口极好,不再胸闷,水肿减轻,血压90,120。继续巩固1疗程后,症状基本消失,再无复发,胎心正常,B超显示胎儿无致畸现象,半年后走访,婴儿很健康,未出现不良副作用。
综合上述可见,本发明的中药可有效的治疗多种症型的妊娠水肿,针对脾虚证型、肾阳虚型、水迫心肺型、气滞水停型、寒湿证型引发的妊娠水肿,具有养血清热、化湿消肿、温肾利水、健脾安胎、理气行滞、散寒去湿、通阳利水之功效。经临床验证本发明的药物对母体、胚胎、胎儿无不良反应,未出现致畸现象,吸收效果较好,方便携带,治愈率高达90%。
Claims (4)
1.一种用于防治妊娠水肿的中药胶囊剂,其特征在于,制成所述中药有效成分的原料组成及重量份数为:
山药15~30份土茯苓15~30份桑枝15~30份土麦冬15~30份
干姜5~15份白术5~15份泽泻5~15份续断5~15份
当归5~15份冬葵子5~15份人参5~15份川芎3~10份
五加皮3~10份赤芍3~10份防己3~10份黄芩3~10份
大腹皮3~10份。
2.根据权利要求1所述的一种用于防治妊娠水肿的中药胶囊剂,其特征在于,制成所述中药有效成分的原料组成及重量份数为:
山药19~26份土茯苓19~26份桑枝19~26份土麦冬19~26份
干姜8~12份白术8~12份泽泻8~12份续断8~12份
当归8~12份冬葵子8~12份人参8~12份川芎4~7份
五加皮4~7份赤芍4~7份防己4~7份黄芩4~7份
大腹皮4~7份。
3.根据权利要求1所述的一种用于防治妊娠水肿的中药胶囊剂,其特征在于,制成所述中药有效成分的原料组成及重量份数为:
山药25份土茯苓25份桑枝25份土麦冬25份
干姜10份白术10份泽泻10份续断10份当归10份
冬葵子10份人参10份川芎5份五加皮5份
赤芍5份防己5份黄芩5份大腹皮5份。
4.根据权利要求1~3所述的一种用于防治妊娠水肿的中药胶囊剂的制备方法,其特征在于,包括以下工艺步骤:
(1)先将麸皮撒入热锅内,候烟冒出时,将山药、白术、泽泻分别倒入微炒至表面呈淡黄色,取出,筛去麸皮后放凉,粉碎成粉末,过80目筛,备用;
(2)将土茯苓、桑枝、土麦冬、干姜、冬葵子、人参、防己、大腹皮分别拣去杂质,粉碎成粉末,过80目筛,备用;
(3)将当归、川芎、五加皮、黄芩分别拣去杂质,洗净,切片晒干,取当归片、川芎片、五加皮、黄芩片分别喷淋绍兴黄酒(与绍兴黄酒分比为10:1),拌匀,用文火微炒至表面呈微黄色,取出,放凉,粉碎成粉末,过80目筛,备用;
(4)将续断、赤芍分别去拣去杂质,洗净后切片,晒干,取续断片、赤芍片分别入锅内以文火炒至表面微焦,取出,放凉,粉碎成粉末,过80目筛,备用;
(5)将步骤1、步骤2、步骤3、步骤4所得的粉末,倒入容器中混合拌匀,加入药量的9倍量的水进行煎煮至沸腾后,继续用文火煎煮40分钟,滤出药液,将滤得的药液浓缩至为75℃环境下相对密度1.20的稠膏,进行低温干燥,粉碎,加入适量糊精,混匀,制粒,低温干燥,整粒,装入胶囊,即得。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510945624.5A CN105381441A (zh) | 2015-12-17 | 2015-12-17 | 一种用于防治妊娠水肿的中药胶囊剂及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510945624.5A CN105381441A (zh) | 2015-12-17 | 2015-12-17 | 一种用于防治妊娠水肿的中药胶囊剂及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105381441A true CN105381441A (zh) | 2016-03-09 |
Family
ID=55414617
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510945624.5A Pending CN105381441A (zh) | 2015-12-17 | 2015-12-17 | 一种用于防治妊娠水肿的中药胶囊剂及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105381441A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105999007A (zh) * | 2016-07-19 | 2016-10-12 | 宓鑫 | 一种治疗水肿的中药组合物 |
CN105999008A (zh) * | 2016-07-19 | 2016-10-12 | 宓鑫 | 一种治疗妊娠水肿的中药组合物 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001031579A (ja) * | 1999-07-16 | 2001-02-06 | Karita Takahisa | 浮腫防止用精油組成物および浮腫防止剤 |
CN101152366A (zh) * | 2007-09-17 | 2008-04-02 | 尹克山 | 治疗妊娠水肿的中药 |
CN105079548A (zh) * | 2015-08-31 | 2015-11-25 | 南京正宽医药科技有限公司 | 一种治疗妊娠水肿的药物制剂 |
-
2015
- 2015-12-17 CN CN201510945624.5A patent/CN105381441A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001031579A (ja) * | 1999-07-16 | 2001-02-06 | Karita Takahisa | 浮腫防止用精油組成物および浮腫防止剤 |
CN101152366A (zh) * | 2007-09-17 | 2008-04-02 | 尹克山 | 治疗妊娠水肿的中药 |
CN105079548A (zh) * | 2015-08-31 | 2015-11-25 | 南京正宽医药科技有限公司 | 一种治疗妊娠水肿的药物制剂 |
Non-Patent Citations (2)
Title |
---|
张昱: "《水肿》", 31 August 2007, 科学技术文献出版社 * |
李昭荣等: "中药治疗妊娠水肿30例", 《陕西中医》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105999007A (zh) * | 2016-07-19 | 2016-10-12 | 宓鑫 | 一种治疗水肿的中药组合物 |
CN105999008A (zh) * | 2016-07-19 | 2016-10-12 | 宓鑫 | 一种治疗妊娠水肿的中药组合物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103301436A (zh) | 一种减肥降脂的药物 | |
CN104784673A (zh) | 一种用于小儿腹泻的中药脐贴 | |
CN105362650A (zh) | 一种用于治疗便秘的药物组合物及其应用方法 | |
CN105148249A (zh) | 一种用于治疗经行浮肿的中药丸剂及制备方法 | |
CN104069162A (zh) | 一种治疗痛风性关节炎及各种骨关节疼痛的中药 | |
CN105381441A (zh) | 一种用于防治妊娠水肿的中药胶囊剂及制备方法 | |
CN104043058A (zh) | 一种治疗肾虚型腰椎间盘突出的中药制剂及其制备方法 | |
CN104225532A (zh) | 治疗强直性脊柱炎的健脾温肾丸 | |
CN103432274B (zh) | 一种治疗偏头痛的药物及其制备方法 | |
CN102872420B (zh) | 一种治疗风湿性关节炎的药物及其制备方法 | |
CN102805825B (zh) | 一种治疗皮肤瘙痒症的药物及其制备方法 | |
CN106389950A (zh) | 一种治疗慢性肾炎综合征蛋白尿的中药制剂 | |
CN105381128A (zh) | 一种辅助针灸治疗外周神经麻痹的中药冲剂及制备方法 | |
CN112023010A (zh) | 一种瘦身用中药组合物及其制备方法、口服药剂和应用 | |
CN105250806A (zh) | 一种治疗妇科月经不调用调经膏及其制备方法 | |
CN105250569A (zh) | 一种用于治疗末梢神经炎的中药丸剂及制备方法 | |
CN104398822A (zh) | 一种治疗肾虚型子宫脱垂的中药及制备方法 | |
CN105434934A (zh) | 一种用于治疗妇科更年期综合症的中药丸剂及制备方法 | |
CN105477462A (zh) | 一种用于治疗肥胖症的中药丸剂及制备方法 | |
CN105687666A (zh) | 一种治疗慢性痛风性关节炎的中药组合物及其制备方法 | |
CN103623377B (zh) | 一种治疗痹症的药物及其制备方法 | |
CN104940777A (zh) | 一种治疗肝旺脾弱型经行泄泻的冲剂及其制备方法 | |
CN105031562A (zh) | 活血润燥酒 | |
CN104491364A (zh) | 一种治疗慢性淋巴细胞性甲状腺炎的药丸及制备方法 | |
CN103877226A (zh) | 具有滋肝补肾功效的豆腐黄鳝粥品及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160309 |
|
RJ01 | Rejection of invention patent application after publication |